Data / Form D filings / Islet Sciences, Inc.
Islet Sciences, Inc.: Form D filings
Islet Sciences, Inc., a biotechnology company in Yorba Linda, CA, filed 8 Form D notices with the SEC between 2012 and 2015. The latest, on December 31, 2015, reports $30,000 sold of a $1.5 million offering to 1 investor.
Find out what Islet Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18340 YORBA LINDA BLVD., SUITE 107-245, Yorba Linda, CA, 92886
- Phone
- (866) 878-9695
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1425919
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2015 | New notice | $1,500,000 | $30,000 | $1,470,000 | 1 | Dec 18, 2015 | sec.gov |
| Apr 28, 2014 | Amendment | $2,500,000 | $2,222,500 | $277,500 | 35 | Dec 4, 2013 | sec.gov |
| Apr 25, 2014 | Amendment | $2,500,000 | $2,222,500 | $277,500 | 35 | Dec 4, 2013 | sec.gov |
| Feb 25, 2014 | New notice | $2,500,000 | $695,000 | $1,805,000 | 22 | Dec 4, 2013 | sec.gov |
| May 15, 2012 | Amendment | $4,500,000 | $4,222,265 | $277,735 | 71 | Mar 20, 2012 | sec.gov |
| Apr 5, 2012 | New notice | $2,170,000 | $1,403,515 | $766,485 | 17 | Mar 20, 2012 | sec.gov |
| Mar 16, 2012 | New notice | $1 | $1 | $0 | 28 | Mar 14, 2012 | sec.gov |
| Jan 11, 2012 | New notice | $1 | $1 | $0 | 71 | Dec 30, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eugene M. Mannheimer | Director | |
| Richard D. Pilnik | Director | |
| John F. Steel | Director | |
| David E. Wilder | Executive Officer | |
| Larry K. Ellingson | Executive Officer, Director | |
| James A. Harper | Director | |
| Gary R. Keeling | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Dec 28, 2015 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Islet Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.